Skip to main content

Showing results for Research Findings

IU researchers study relationship between epilepsy drug and Alzheimer’s disease

Researchers from an Indiana University School of Medicine-led consortium of Alzheimer’s disease experts are studying how an anti-seizure drug used to treat epilepsy in children and adults could be repurposed as a potential therapeutic for Alzheimer’s disease.

IU School of Medicine  |  Nov 30, 2022

IU research contributes to first FDA-approved drug to delay onset of type 1 diabetes

Researchers at Indiana University School of Medicine are celebrating Federal Drug Administration approval of teplizumab, a new immunotherapy drug that delays the onset of type 1 diabetes in at-risk individuals by an average of almost three years.

IU School of Medicine  |  Nov 21, 2022

IU researchers identify protein that contributes to tau neurotoxicity in Alzheimer’s disease

Researchers from Indiana University School of Medicine have identified a protein that interacts and enhances the spread of neurotoxic species of tau—which is primarily found in neurons that appear abnormal in the brains of Alzheimer’s disease patients.

New informatics software developed by IU School of Medicine researcher helps identify rare genetic variants

A team of researchers at Indiana University School of Medicine has developed specialized bioinformatics software designed to identify rare genetic variants in whole-genome sequencing studies.

IU researchers investigate brain’s immune cell response in Alzheimer’s disease

Indiana University School of Medicine researchers are investigating how the deficiency of a gene in immune cells can shape the progression of Alzheimer’s disease.

Researchers studying new way to heal diabetic wounds by activating “hidden” mechanism in the body

Researchers at Indiana University School of Medicine are looking for ways to heal wounds by using a healing protein that is active in fetuses, but largely inactive in adults and absent in diabetic adults.

Iron induces chronic heart failure in half of heart attack survivors, according to landmark study led by IU researcher

A multi-institution study led by Rohan Dharmakumar, PhD, of Indiana University School of Medicine, has identified that iron drives the formation of fatty tissue in the heart and leads to chronic heart failure in about fifty percent of heart attack survivors.

Study: high exposure to glyphosate in pregnancy could cause lower birth weights in babies

Indiana University School of Medicine researchers are learning more about the effects of herbicide exposure during pregnancy.

Christina Griffiths  |  Oct 12, 2022

Researchers identify potential therapeutic targets to prevent hearing loss caused by antibiotics

Researchers at Indiana University School of Medicine are developing new ways to study why an antibiotic causes hair cell death and permanent hearing loss in people.

IU School of Medicine  |  Sep 26, 2022

Alzheimer’s researchers study drug efficacy in early stages of disease

Most drugs developed to treat Alzheimer’s disease have for years been ineffective in clinical trials. Researchers from Indiana University School of Medicine recently evaluated the efficacy of a failed clinical trial drug using their rigorous pipeline.

IU School of Medicine  |  Jul 25, 2022